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INTRODUCTION 
Gastric subepithelial tumors (SETs) are commonly en-
countered during upper endoscopic examination, and 
with the widespread use of screening endoscopy, the 
detection rate of SETs has continued to increase. Large 
SETs and symptomatic lesions that require surgical treat-
ment usually do not require a pre-operative tissue diag-
nosis [1]. Small SETs, especially lesions less than 1 cm in 
size, are recommended for regular endoscopic follow-up 
without tissue diagnosis or treatment [2]. However, in-
termediate-sized lesions require a differential diagnosis 
due to the difference in therapeutic approaches between 
SETs with and without malignant potential. Tissue diag-
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Background/Aims: To evaluate the therapeutic outcomes of the endoscopic sub-
mucosal dissection (ESD) technique for the treatment of gastric subepithelial tu-
mors (SETs). 
Methods: A systematic literature review was conducted using the core databases. 
Data on the complete resection rates and the procedure-related perforation rates 
were extracted and analyzed. A random effects model was then applied for this 
meta-analysis. 
Results: In all, 288 patients with 290 SETs were enrolled from nine studies (44 
SETs originated from the submucosal layer; 246 SETs originated from the mus-
cularis propria layer). The mean diameter of the lesions ranged from 17.99 to 38 
mm. Overall, the pooled complete resection rate was estimated to be 86.2% (95% 
confidence interval [CI], 78.9 to 91.3). If the analysis was limited to the lesions that 
originated from the submucosal layer, the pooled complete resection rate was 
91.4% (95% CI, 77.9 to 97). If the analysis was limited to the lesions that originated 
from the muscularis propria, the pooled complete resection rate was 84.4% (95% 
CI, 78.7 to 88.8). The pooled procedure-related gastric perforation rate was 13% (95% 
CI, 9.4 to 17.6). Sensitivity analyses showed consistent results. Finally, publication 
bias was not detected. 
Conclusions: ESD, including endoscopic muscularis dissection, is a technically 
feasible procedure for the treatment of SETs. However, selection bias is suspected 
from the enrolled studies. For the development of a proper indication of ESD for 
SETs, further studies are needed.
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nosis is difficult because SETs are covered with normal 
epithelium, and the layer of origin cannot be assessed by 
conventional endoscopy. Periodic endoscopy with en-
doscopic ultrasound (EUS) is usually performed for this 
type of lesion in order to characterize and identify SETs; 
in addition, the hypoechoic masses that may originate 
from the 3rd or 4th echo layer require histological con-
firmation [3]. However, no consensus exists as to the use 
of endoscopic biopsy, and due to the risk of tumor seed-
ing, histological confirmation through surgery has been 
suggested, especially for lesions that are suspected to be 
gastrointestinal stromal tumors (GISTs) [4]. Although all 
GIST lesions have the potential for malignancy, contro-
versies persist in regards to whether surgical morbidity 
or mortality is acceptable in the removal of SETs includ-
ing lesions with low malignant potential [1,5].
With the advancement of endoscopic skills and exper-
tise, endoscopic submucosal dissection (ESD) has been 
performed in order to obtain tissue specimens, not only 
for lesions that are located in the submucosal (SM) layer, 
but even for those in the muscularis propria (MP) [6]. 
ESD allows for dissection below the tumor under direct 
vision [7]. Due to the potential of organ preservation and 
the less invasive nature of the ESD technique compared 
with surgical treatments, ESD might be preferred if 
therapeutic outcomes including safety indices are sat-
isfied. The aim of this study was to evaluate the current 
evidence in regards to the therapeutic outcomes of ESD 
for the treatment of gastric SETs.
METHODS
Literature search
MEDLINE (through PubMed), EMBASE, and the Co-
chrane Central Register of Controlled Trials (CENTRAL) 
in the Cochrane Library were searched using common 
keywords related to ESD for the treatment of gastric 
SETs (from inception to July 2014). Medical Subject 
Headings (MeSH) terminology and user keywords that 
are commonly used in relevant articles were selected. 
The keywords included ‘endoscopic submucosal dis-
section,’ ‘ESD,’ ‘endoscopic resection,’ ‘subepithelial 
tumors,’ ‘SET,’ ‘submucosal tumors,’ and ‘SMT’ using 
Boolean operators. Only publications on human sub-
jects were sought, and the bibliographies of relevant ar-
ticles were also reviewed in order to identify additional 
studies. 
Selection criteria
We included studies that met the following criteria: (1) 
the study was designed to evaluate the efficacy of ESD 
including endoscopic muscularis dissection for the 
treatment of gastric SETs and (2) the study included 
therapeutic outcomes (complete resection rate, recur-
rence rate or procedure-related adverse event rate) that 
enabled an evaluation of the feasibility of ESD for gastric 
SETs. The exclusion criteria were as follows: (1) studies 
with incomplete data, (2) review articles, (3) animal stud-
ies, or (4) letters or case articles. 
Selection of relevant studies
Two of the authors (C.S.B. and G.H.B.) independently 
evaluated the eligibility of all studies that were retrieved 
from the databases. The evaluation was based on the 
predetermined selection criteria. The abstracts of all 
identified studies were reviewed to exclude irrelevant 
articles. Full-text reviews were performed to determine 
whether the inclusion criteria were satisfied by the re-
maining studies. Disagreements between the two eval-
uators were resolved by discussion or by consultation 
with a third author (D.J.K.).
Assessment of methodological quality
The methodological quality of the enrolled studies was 
assessed with the Newcastle-Ottawa scale. This tool 
comprises the following three parameters: the selection 
of the study population, the comparability of the groups, 
and the ascertainment of the exposure or outcome. Each 
parameter consists of subcategorized questions as fol-
lows: selection (n = 4), comparability (n = 1), and exposure 
or outcome (n = 3) [8,9]. The stars awarded for each item 
allow for a rapid visual assessment of the methodologi-
cal quality of the studies. A study can be awarded a max-
imum of nine stars, which indicates the highest quality. 
Two of the authors (C.S.B. and G.H.B.) independently 
evaluated the methodological quality of all the studies, 
and disagreements between the two evaluators were re-
solved by discussion or by consultation with a third au-
thor (D.J.K.). 
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Primary and modifier-based analyses
Two of the authors (C.S.B. and G.H.B.) independently 
extracted the outcomes of all the studies, and disagree-
ments between the two evaluators were resolved by dis-
cussion or by consultation with a third author (D.J.K.). 
The primary outcomes were as follows: (1) complete re-
section rate, which was the proportion of removed SETs 
with no components at the lateral or vertical margins 
on microscopic analysis; (2) recurrence rate, which was 
the proportion of SETs that reappeared at the site of the 
lesion (local recurrence) or synchronous, metachronous, 
or distant metastatic lesions; and (3) adverse event rate, 
which was the proportion of SETs whose treatment re-
sulted in procedure-related gastric hemorrhage or per-
foration. We also performed sensitivity analyses based 
on the origin of the SETs in terms of the gastric layer 
and on the lesions that were confirmed to be GISTs. 
Both a cumulative analysis and a one-study-removed 
analysis were also performed. 
Statistics
Comprehensive Meta-Analysis (CMA) software version 
2.2.064 (Biostat; Borenstein M, Hedges L, Higgins J, and 
Rothstein H. Englewood, NJ, USA) was used for this me-
ta-analysis. We calculated the pooled complete resection 
rate and the adverse event rate with 95% confidence in-
tervals (CIs) from the enrolled studies. Heterogeneity 
was determined using the I2 test, which was developed 
by Higgins; this test measures the percentage of total 
variation across studies [10]. I2 was calculated with the 
following formula: I2 (%) = 100 × (Q-df) / Q, where Q is 
Cochrane’s heterogeneity statistic and df signifies the 
degree of freedom. Negative values for I2 were set to zero, 
and an I2 value over 50% was considered to be of substan-
tial heterogeneity (range, 0% to 100%) [11]. Pooled-effect 
sizes with 95% CIs were calculated with a random effects 
model and with the method of DerSimonian and Laird 
[12]. These results were confirmed by the I2 test. A fixed 
effects model that included the inverse variance-weight-
ed (Woolf’s) method was used in the sensitivity analyses, 
including cumulative and one-study-removed analyses, 
based on the assumption of a common effect size shared 
by the studies within each subgroup [13,14]. Significance 
was set at p = 0.05 in both models. Publication bias was 
evaluated with Begg’s funnel plot, Egger’s test of the in-
tercept, Duval and Tweedie’s trim and fill, and Begg and 
Mazumdar’s rank correlation test [15-19].
RESULTS
Identification of relevant studies
Fig. 1 contains a flow diagram that shows how rele-
vant studies were identified. A total of 163 articles were 
identified by a search of three core databases. In all, 54 
duplicate studies and an additional 92 studies were ex-
cluded during the initial screening through a review of 
the titles and abstracts. The full texts of the remaining 
17 studies were then thoroughly reviewed. Among these 
studies, eight were excluded from the final analysis. The 
reasons for study exclusion during the final review were 
as follows: review article (n = 2) or incomplete data (n 
= 6). The remaining nine studies were included in the 
final analysis [7,20-27].
Characteristics of the studies
Within the nine studies, we identified a total of 290 
SETs from 288 patients (98 men and 190 women; 44 
SETs originated from the SM layer and 246 SETs orig-
inated from the MP layer). The clinical characteristics 
of the patients from the included studies are shown in 
Tables 1 and 2. The included studies were published 
between 2006 and 2013. Seven studies were conducted 
in Asia [7,20,23-27] (three studies in China [24,25,27], two 
163 Records identified through 
      database searching 
      56 PubMed
        9 Cochrane Library
      98 EMBASE 
0 Additional records identified
through hand serching
109 Records after duplicates removed
109 Records screened 92 Records excluded
     during screening of 
     title and abstract
17 Full-text articles assessed for eligibility
9 Studies included in qualitative synthesis
9 Studies included in qualitative synthesis
(meta-analysis)
8 Full-text articles excluded, 
   with reasons
   2 Review article
   6 Incomplete data
Figure 1. Flow diagram for identification of relevant studies.
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studies in Japan [7,23], one study in Korea [26], and one 
study in Taiwan [20]), and two studies were conducted in 
Europe (one study in Poland [21], and one study in Italy 
[22]). All of the included studies were written in English.
The age of the enrolled patients ranged from 52.3 ± 
18.2 to 65.3 ± 6.3 (mean ± SD). The diameter of the le-
sions ranged from 17.99 ± 7.86 to 38 ± 22.1 mm. The pro-
cedure time ranged from 32.29 ± 20.55, and the median 
procedure time was 119.1 minutes (range, 40 to 240). The 
procedure was performed under general anesthesia in 
235 patients and under conscious sedation in 53 patients. 
Symptoms were present in 84 of the 216 identifiable pa-
tients. The symptoms were as follows: abdominal pain, 
discomfort, or heartburn (n = 65), gastrointestinal hem-
orrhage (n = 10), other symptoms (n = 7), or unidentifi-
able symptoms (n = 2). The follow-up duration after ESD 
ranged from a median of 4 months (range, 18 to 36) to 21 
months (range, 6 to 48).
In terms of the methodological quality, the mean val-
ue of the awarded star was 4.56 (four stars [four studies] 
and 5 stars [five studies]) (Table 3). The enrolled studies 
shared relatively similar methodological quality, and 
thus, a sensitivity analysis based on the methodological 
quality was not performed.
Overall efficacy and safety of ESD for the treatment 
of gastric SETs
The overall efficacy of ESD for gastric SETs was evalu-
ated using the complete resection rate, the recurrence 
rate, the survival rate, and the procedure-related adverse 
Study
Lee et al. (2006) [20]
Hoteya et al. (2009) [7]
Bialek et al. (2012) [21]
Catalano et al. (2013) [22]
Kobara et al. (2013) [23]
He et al. (2013) [24]
Zhang et al. (2013) [25]
Chun et al. (2013) [26]
Li et al. (2013) [27]
Statistice for each study
Event rate
0.750
0.950
0.811
0.900
0.875
0.924
0.944
0.734
0.909
0.862
Lower limit
0.448
0.525
0.653
0.676
0.266
0.868
0.693
0.575
0.561
0.789
Upper limit
0.917
0.997
0.907
0.975
0.993
0.957
0.992
0.860
0.987
0.913
Z value
1.648
2.029
3.467
2.948
1.287
7.971
2.753
2.743
2.195
6.929
       p value
0.099
0.042
0.001
0.003
0.198
0.000
0.006
0.006
0.028
0.000
Event rate and 95% CI
Pooled complete resection rate
Heterogeneity: Χ2 = 12.501, df = 8 (p = 0.130); I2 = 36.006%
Test for overall effect: Z = 6.929 (p < 0.001)
–1.00 –0.50 0.00 0.50 1.00
Figure 2. Total complete resection rate of enrolled studies. The size of each square is proportional to the study’s weight. Dia-
mond is the summary estimate from the pooled studies (random effect model). CI, confidence interval.
Study
Lee et al. (2006) [20]
Hoteya et al. (2009) [7]
Bialek et al. (2012) [21]
Catalano et al. (2013) [22]
Kobara et al. (2013) [23]
He et al. (2013) [24]
Zhang et al. (2013) [25]
Chun et al. (2013) [26]
Li et al. (2013) [27]
Statistice for each study
Event rate
0.038
0.050
0.054
0.150
0.125
0.145
0.111
0.057
0.300
0.130
Lower limit
0.002
0.003
0.014
0.049
0.007
0.096
0.028
0.014
0.100
0.094
Upper limit
0.403
0.475
0.192
0.376
0.734
0.212
0.352
0.202
0.624
0.176
Z value
–2.232
–2.029
–3.937
–2.770
–1.287
–7.525
–2.773
–3.850
–1.228
–10.353
         p value
0.026
0.042
0.000
0.006
0.198
0.000
0.006
0.000
0.220
0.000
Event rate and 95% CI
Pooled procedure-related           gastric perforation rate
Heterogeneity: Χ2 = 7.377, df = 8 (p = 0.497); I2 = 0%
Test for overall effect: Z = -10.353 (p < 0.001)
–0.25 –0.13 0.00 0.13 0.25
Figure 3. Total procedure-related adverse event rate of enrolled studies (gastric perforation). The size of each square is propor-
tional to the study’s weight. Diamond is the summary estimate from the pooled studies (random effect model). CI, confidence 
interval.
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event rate. The pooled complete resection rate was esti-
mated to be 86.2% (95% CI, 78.9 to 91.3; p < 0.001) (Fig. 2). 
The recurrence rate was not given in the enrolled stud-
ies, and no cases of disease or procedure-related mortal-
ity were reported. The pooled procedure-related gastric 
perforation rate was 13% (95% CI, 9.4 to 17.6; p < 0.001) 
(Fig. 3). Among the 34 SETs that were incompletely re-
sected, 20 cases were diagnosed as leiomyoma, 10 cases 
were GISTs, one case was an ectopic pancreas, one case 
was a neurogenic tumor, and two cases were unknown 
(Table 1).
Sensitivity meta-analysis
Sensitivity analyses were performed to show the robust-
ness of the results of the main analysis. If the analysis 
was limited to the lesions that originated in the SM lay-
er, the pooled complete resection rate was 91.4% (95% 
CI, 77.9 to 97; p < 0.001) (Fig. 4A). If the analysis was lim-
ited to the lesions that originated in the MP layer, the 
pooled complete resection rate was 84.4% (95% CI, 78.7 
to 88.8; p < 0.001) (Fig. 4B). If the analysis was limited 
to the lesions that were diagnosed as GISTs, the pooled 
complete resection rate was 82.7% (95% CI, 70.5 to 90.6; 
p < 0.001) (Fig. 4C). The pooled procedure-related gastric 
perforation rate of GISTs was 20.5% (95% CI, 10.8 to 35.4; 
p < 0.001) (Fig. 4D). Among the eight cases of gastric per-
foration that were associated with GISTs, six cases orig-
inated in the MP and two cases originated in the SM.
The cumulative meta-analysis of the enrolled studies 
in the order of year published showed a constant and 
slightly increasing trend in the complete resection rate 
and the procedure-related gastric perforation rate (Fig. 
5). The one study-removed meta-analysis of the enrolled 
studies in the order of the year published showed con-
sistent results (Fig. 6). The study by He et al. [24] demon-
strated the most influential effect. This study has the 
largest enrolled population, and the methodological 
quality was relatively high among the enrolled studies. 
Publication bias
A funnel plot for the included studies is illustrated in 
Fig. 7. These plots show a symmetrical shape. 
In the publication bias analysis of the complete resec-
tion rate, Egger’s regression test revealed that the inter-
cept was 0.33 (95% CI, –1.86 to 2.51; t value, 0.35; df, 7; p = 
0.37 [1-tailed] and p = 0.73 [2-tailed]). A trim and fill anal-
ysis showed that two studies were missed or trimmed. 
The rank correlation test indicated a Kendall’s tau of 
0.08 with a continuity correction (p = 0.38 [1-tailed] and 
p = 0.75 [2-tailed]). 
In the publication bias analysis of the procedure-re-
lated gastric perforation rate, Egger’s regression test re-
vealed that the intercept was –0.72 (95% CI, –1.99 to 0.55; 
t value, 1.34; df, 7; p = 0.11 [1-tailed] and p = 0.22 [2-tailed]). 
A trim and fill analysis demonstrated that two studies 
were missed or trimmed. The rank correlation test in-
dicated a Kendall’s tau of –0.14 with a continuity correc-
tion (p = 0.30 [1-tailed] where p = 0.60 [2-tailed]). 
Overall, no evidence of publication bias was observed 
in this analysis.
DISCUSSION
According to the present study, ESD was found to be 
a technically feasible treatment modality for the treat-
Table 3. Methodological quality of included studies measured by Newcastle-Ottawa scale
Study Selection Comparability Exposure or outcome Total score
Lee et al. (2006) [20] ☆☆☆ - ☆ 4
Hoteya et al. (2009) [7] ☆☆☆ - ☆☆ 5
Bialek et al. (2012) [21] ☆☆☆ - ☆ 4
Catalano et al. (2013) [22] ☆☆☆ - ☆ 4
Kobara et al. (2013) [23] ☆☆ - ☆☆ 4
He et al. (2013) [24] ☆☆☆ - ☆☆ 5
Zhang et al. (2013) [25] ☆☆☆ - ☆☆ 5
Chun et al. (2013) [26] ☆☆☆ - ☆☆ 5
Li et al. (2013) [27] ☆☆☆ - ☆☆ 5
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ment of SETs. The overall complete resection rate was 
86.2%, which increased to 91.4% for lesions that origi-
nated in the SM. However, for the lesions that originat-
ed in the MP layer and for GISTs, the complete resection 
rate slightly decreased to 84.4% and 82.7%, respectively. 
The procedure-related perforation rate was 13%, which 
Study
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Figure 4. Sensitivity analysis. (A) Complete resection rate of lesions originated from the submucosal layer. (B) Complete resec-
tion rate of lesions originated from the muscularis propria layer. (C) Complete resection rate of gastrointestinal stromal tumor 
(GIST). (D) Total procedure-related gastric perforation rate of GIST. CI, confidence interval.
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increased to 20.5% for the lesions that were diagnosed 
as GISTs. 
Therapeutic outcomes that were commonly shared 
among studies relevant to this topic were the complete 
resection rate, the recurrence rate, the survival rate and 
the procedure-related adverse event rate, especially the 
gastric perforation rate. However, the meaning of these 
indices is not fully understood with respect to the treat-
ment of SETs. Complete resection was not based on the 
surgical specimens in order to confirm the complete-
ness of the resection. Moreover, the follow-up duration 
was limited to confirm the recurrence or survival and 
whether the complete resection was associated with 
the prognosis [1]. Furthermore, we were unaware as to 
the natural history of the SETs, including GISTs, in 
our study [2,28]. The enrolled studies did not include 
an analysis divided by low-risk and high-risk GISTs. 
One of the main obstacles in the use of ESD for SETs 
is the deep location of these lesions. It is obvious that 
lesions in the MP layer are more likely to be perforat-
ed by ESD. However, the majority of the cases from the 
enrolled studies were managed by endoscopic clipping 
without additional surgical treatments. Thus, the proce-
dure-related gastric perforation rate might also be less 
significant, although the low perforation rate should be 
maintained. To clarify the meaning of the therapeutic 
outcomes, large-scale, long-term studies are needed.
Another issue is the technique of ESD. Several varia-
tions of ESD for the removal of gastric SETs have been 
performed including the following: endoscopic mus-
cularis dissection, endoscopic SM tunnel dissection, 
endoscopic enucleation, or endoscopic full-thickness 
resection with laparoscopic assistance, and laparoscop-
ic and endoscopic cooperative surgery [29]. Endoscopic 
muscularis dissection is the procedure that is used for 
the removal of SETs that originate in the MP layer; in 
this method, the underlying proper muscle is dissected 
away from the tumor [29,30]. Thus, this method could 
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Figure 5. Cumulative meta-analysis of enrolled studies. (A) For complete resection rate. (B) For procedure-related adverse event 
rate of enrolled studies (gastric perforation). CI, confidence interval.
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be distinguished from traditional ESD. However, in this 
meta-analysis, none of the enrolled studies differenti-
ated these procedures, but rather, the traditional ESD 
technique was applied directly for the removal of SETs 
that originated in the MP. Therefore, therapeutic out-
comes of ESD including endoscopic muscularis dissec-
tion were combined, and sensitivity analyses were per-
formed and divided by the SET according to the layer 
of origin. Although this meta-analysis included only the 
ESD procedure, the various techniques described above 
Study
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Figure 6. One study removed meta-analysis of enrolled studies. (A) For complete resection rate. (B) For procedure-related ad-
verse event rate of enrolled studies (gastric perforation). CI, confidence interval.
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are a candidate to be the mainstay of future treatment 
modalities.
Despite the technical feasibility of ESD for the treat-
ment of gastric SETs, as described above, the most im-
portant issue is the establishment of indications. The 
selection criteria for the patients were similar among 
the enrolled studies, although a size discrepancy was 
noted among the indications (Table 2). Only EUS was 
performed to determine the indications for the patients 
in all of the enrolled studies. Additionally, the layer in 
which the tumors originated, whether the tumors were 
of the extraluminal or intraluminal type, and the find-
ings that indicated benign lesions such as lipoma or 
malignant lesions such as GIST were described. Howev-
er, considering that in one of the enrolled studies, EUS 
was only accurate in 73% of the lesions for the determi-
nation of the layer of tumor origin, another diagnostic 
modality or factor should be added for the determina-
tion of the indications [21]. Extraluminal type SETs and 
large-sized lesions were commonly excluded because of 
the technical difficulties and the high perforation risk. 
However, other factors such as a wide base or a narrow 
base, whether the lesions were well-demarcated or not, 
and whether endoscopic or EUS findings predicted the 
adhesion severity were not included in the indications.
This study is the first meta-analysis on the efficacy 
of ESD for the treatment of SETs. The strength of this 
study is the rigorous literature search. When possible, 
potential modifiers were detected within the articles, 
and sensitivity analyses were performed to confirm the 
robustness of the results. Despite the strengths, there 
are also several limitations. First, the number of en-
rolled patients in each study was too small. Each study 
has a potential of selection bias, and thus, the enrolled 
population might be heterogeneous. Second, the fol-
low-up duration was too short. With the data from this 
meta-analysis, it is impossible to predict the long-term 
efficacy or the prognostic indices. Third, the experience 
and skill of the endoscopists with respect to ESD were 
not considered. ESD, including endoscopic muscularis 
dissection, is a highly complicated procedure that re-
quires a high level of skill. The therapeutic outcomes in-
cluding the procedure-related adverse event rates might 
be dependent on the experience of endoscopists. The 
limitations described above could also be a cause of het-
erogeneity and bias. Large-scale, well-organized, long-
term follow-up studies are therefore needed to establish 
proper indications of ESD for the treatment of SETs. 
In conclusion, ESD including endoscopic muscularis 
dissection is a technically feasible procedure for the di-
agnosis and treatment of SETs. For the development of 
proper indications for ESD for the treatment of SETs, 
additional studies are needed.
Conflict of interest
No potential conflict of interest relevant to this article 
was reported.
REFERENCES
1. Hwang JH, Rulyak SD, Kimmey MB; American Gastro-
enterological Association Institute. American Gastroen-
terological Association Institute technical review on the 
management of gastric subepithelial masses. Gastroen-
terology 2006;130:2217-2228.
2. Lim YJ, Son HJ, Lee JS, et al. Clinical course of subepithe-
lial lesions detected on upper gastrointestinal endoscopy. 
World J Gastroenterol 2010;16:439-444.
3. Kojima T, Takahashi H, Parra-Blanco A, Kohsen K, Fujita 
R. Diagnosis of submucosal tumor of the upper GI tract 
by endoscopic resection. Gastrointest Endosc 1999;50:516-
522.
4. Blay JY, Bonvalot S, Casali P, et al. Consensus meeting 
for the management of gastrointestinal stromal tu-
mors: report of the GIST Consensus Conference of 20-
21 March 2004, under the auspices of ESMO. Ann Oncol 
2005;16:566-578.
5. Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gas-
trointestinal stromal tumors: a consensus approach. Int J 
KEY MESSAGE
1. Current evidence indicates endoscopic submu-
cosal dissection (ESD) including endoscopic 
muscularis dissection is technically feasible 
procedure for the treatment of subepithelial tu-
mors (SETs). 
2. However, selection bias is suspected from the 
enrolled studies. For the development of proper 
indication about ESD for SETs, further studies 
are needed.
871
Bang CS, et al. Endoscopic submucosal dissection of gastric subepithelial tumors
www.kjim.orghttp://dx.doi.org/10.3904/kjim.2015.093
Surg Pathol 2002;10:81-89.
6. Goto O, Uraoka T, Horii J, Yahagi N. Expanding indica-
tions for ESD: submucosal disease (SMT/carcinoid tu-
mors). Gastrointest Endosc Clin N Am 2014;24:169-181.
7. Hoteya S, Iizuka T, Kikuchi D, Yahagi N. Endoscopic sub-
mucosal dissection for gastric submucosal tumor, endo-
scopic sub-tumoral dissection. Dig Endosc 2009;21:266-
269.
8. Deeks JJ, Dinnes J, D’Amico R, et al. Evaluating non-ran-
domised intervention studies. Health Technol Assess 
2003;7:1-173.
9. Stang A. Critical evaluation of the Newcastle-Ottawa scale 
for the assessment of the quality of nonrandomized stud-
ies in meta-analyses. Eur J Epidemiol 2010;25:603-605. 
10. Higgins JP, Thompson SG. Quantifying heterogeneity in 
a meta-analysis. Stat Med 2002;21:1539-1558.
11. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measur-
ing inconsistency in meta-analyses. BMJ 2003;327:557-560. 
12. DerSimonian R, Laird N. Meta-analysis in clinical trials. 
Control Clin Trials 1986;7:177-188.
13. Borenstein M, Hedges LV, Higgins JP, Rothstein HR. 
Fixed-effect versus random-effects models. In: Boren-
stein M, Hedges LV, Higgins JP, Rothstein HR, eds. Intro-
duction to Meta-Analysis. Chichester: John Wiley & Sons, 
2009:59-102.
14. Hedges LV, Olkin I. Statistical Methods for Meta-Analysis. 
Orlando: Academic Press, 1985.
15. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-
based method of testing and adjusting for publication 
bias in meta-analysis. Biometrics 2000;56:455-463.
16. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F. 
Methods for Meta-Analysis in Medical Research. Chich-
ester: Wiley, 2000.
17. Sterne JA, Egger M. Funnel plots for detecting bias in 
meta-analysis: guidelines on choice of axis. J Clin Epide-
miol 2001;54:1046-1055.
18. Begg CB, Mazumdar M. Operating characteristics of a 
rank correlation test for publication bias. Biometrics 
1994;50:1088-1101.
19. Egger M, Davey Smith G, Schneider M, Minder C. Bias in 
meta-analysis detected by a simple, graphical test. BMJ 
1997;315:629-634.
20. Lee IL, Lin PY, Tung SY, Shen CH, Wei KL, Wu CS. Endo-
scopic submucosal dissection for the treatment of intra-
luminal gastric subepithelial tumors originating from 
the muscularis propria layer. Endoscopy 2006;38:1024-
1028.
21. Bialek A, Wiechowska-Kozlowska A, Pertkiewicz J, et al. 
Endoscopic submucosal dissection for treatment of gas-
tric subepithelial tumors (with video). Gastrointest En-
dosc 2012;75:276-286.
22. Catalano F, Rodella L, Lombardo F, et al. Endoscopic sub-
mucosal dissection in the treatment of gastric submu-
cosal tumors: results from a retrospective cohort study. 
Gastric Cancer 2013;16:563-570. 
23. Kobara H, Mori H, Rafiq K, et al. Indications of endo-
scopic submucosal dissection for symptomatic benign 
gastrointestinal subepithelial or carcinoid tumors orig-
inating in the submucosa. Mol Clin Oncol 2013;1:1002-
1008. 
24. He Z, Sun C, Wang J, et al. Efficacy and safety of endo-
scopic submucosal dissection in treating gastric subep-
ithelial tumors originating in the muscularis propria 
layer: a single-center study of 144 cases. Scand J Gastroen-
terol 2013;48:1466-1473. 
25. Zhang S, Chao GQ, Li M, Ni GB, Lv B. Endoscopic sub-
mucosal dissection for treatment of gastric submucosal 
tumors originating from the muscularis propria layer. 
Dig Dis Sci 2013;58:1710-1716.
26. Chun SY, Kim KO, Park DS, et al. Endoscopic submucosal 
dissection as a treatment for gastric subepithelial tumors 
that originate from the muscularis propria layer: a pre-
liminary analysis of appropriate indications. Surg Endosc 
2013;27:3271-3279.
27. Li L, Wang F, Wu B, Wang Q, Wang C, Liu J. Endoscopic 
submucosal dissection of gastric fundus subepithelial tu-
mors originating from the muscularis propria. Exp Ther 
Med 2013;6:391-395. 
28. Kim MY, Jung HY, Choi KD, et al. Natural history of as-
ymptomatic small gastric subepithelial tumors. J Clin 
Gastroenterol 2011;45:330-336.
29. Abe N, Takeuchi H, Ooki A, et al. Recent developments 
in gastric endoscopic submucosal dissection: towards 
the era of endoscopic resection of layers deeper than the 
submucosa. Dig Endosc 2013;25 Suppl 1:64-70.
30. Liu BR, Song JT, Qu B, Wen JF, Yin JB, Liu W. Endoscopic 
muscularis dissection for upper gastrointestinal subepi-
thelial tumors originating from the muscularis propria. 
Surg Endosc 2012;26:3141-3148.        
      
www.kjim.org
The Korean Journal of Internal Medicine Vol. 31, No. 5, September 2016
http://dx.doi.org/10.3904/kjim.2016.093
A
pp
en
di
x 
1.
 P
R
IS
M
A
 2
00
9 
ch
ec
kl
is
t
Se
ct
io
n/
to
pi
c 
#
C
he
ck
li
st
 it
em
 
R
ep
or
te
d 
on
 
pa
ge
 #
 
T
IT
LE
 
T
it
le
 
1
Id
en
ti
fy
 th
e 
re
po
rt
 a
s 
a 
sy
st
em
at
ic
 r
ev
ie
w
, m
et
a-
an
al
ys
is
, o
r 
bo
th
. 
4
A
B
ST
R
AC
T
 
St
ru
ct
ur
ed
 s
um
m
ar
y 
2
Pr
ov
id
e 
a 
st
ru
ct
ur
ed
 s
um
m
ar
y 
in
cl
ud
in
g,
 a
s 
ap
pl
ic
ab
le
: b
ac
kg
ro
un
d;
 o
bj
ec
ti
ve
s;
 d
at
a 
so
ur
ce
s;
 s
tu
dy
 e
li
gi
bi
l
 it
y 
cr
ite
ri
a,
 p
ar
ti
ci
pa
nt
s,
 a
nd
 in
te
rv
en
ti
on
s;
 s
tu
dy
 a
pp
ra
is
al
 a
nd
 s
yn
th
es
is
 m
et
ho
ds
; r
es
ul
ts
; l
im
it
at
io
ns
;
 c
on
 c
lu
si
on
s 
an
d 
im
pl
ic
at
io
ns
 o
f k
ey
 fi
nd
in
gs
; s
ys
te
m
at
ic
 r
ev
ie
w
 r
eg
is
tr
at
io
n 
nu
m
be
r. 
4
IN
T
R
O
D
U
C
T
IO
N
 
R
at
io
na
le
 
3
D
es
cr
ib
e 
th
e 
ra
ti
on
al
e 
fo
r 
th
e 
re
vi
ew
 in
 th
e 
co
nt
ex
t o
f w
ha
t i
s 
al
re
ad
y 
kn
ow
n.
 
5
O
bj
ec
ti
ve
s 
4
Pr
ov
id
e 
an
 e
xp
lic
it 
st
at
em
en
t o
f q
ue
st
io
ns
 b
ei
ng
 a
dd
re
ss
ed
 w
it
h 
re
fe
re
nc
e 
to
 p
ar
ti
ci
pa
nt
s,
 in
te
rv
en
ti
on
s,
 
 c
om
pa
ri
so
ns
, o
ut
co
m
es
, a
nd
 s
tu
dy
 d
es
ig
n 
(P
IC
O
S)
. 
5
M
ET
H
O
D
S 
Pr
ot
oc
ol
 a
nd
 r
eg
is
tr
at
io
n 
5
In
di
ca
te
 if
 a
 r
ev
ie
w
 p
ro
to
co
l e
xi
st
s,
 if
 a
nd
 w
he
re
 it
 c
an
 b
e 
ac
ce
ss
ed
 (e
.g
., 
W
eb
 a
dd
re
ss
), 
an
d,
 if
 a
va
il
ab
le
, p
ro
vi
de
 
 r
eg
is
tr
at
io
n 
in
fo
rm
at
io
n 
in
cl
ud
in
g 
re
gi
st
ra
ti
on
 n
um
be
r. 
El
ig
ib
il
it
y 
cr
ite
ri
a 
6
Sp
ec
if
y 
st
ud
y 
ch
ar
ac
te
ri
st
ic
s 
(e
.g
., 
PI
C
O
S,
 le
ng
th
 o
f f
ol
lo
w
-u
p)
 a
nd
 r
ep
or
t c
ha
ra
ct
er
is
ti
cs
 (e
.g
., 
ye
ar
s 
 c
on
si
d 
er
ed
, l
an
gu
ag
e,
 p
ub
lic
at
io
n 
st
at
us
) u
se
d 
as
 c
ri
te
ri
a 
fo
r 
el
ig
ib
il
it
y,
 g
iv
in
g 
ra
ti
on
al
e.
 
6
In
fo
rm
at
io
n 
so
ur
ce
s 
7
D
es
cr
ib
e 
al
l i
nf
or
m
at
io
n 
so
ur
ce
s 
(e
.g
., 
da
ta
ba
se
s 
w
it
h 
da
te
s 
of
 c
ov
er
ag
e,
 c
on
ta
ct
 w
it
h 
st
ud
y 
au
th
or
s 
to
 id
en
ti
fy
 
 a
dd
it
io
na
l s
tu
di
es
) i
n 
th
e 
se
ar
ch
 a
nd
 d
at
e 
la
st
 s
ea
rc
he
d.
 
6
Se
ar
ch
 
8
Pr
es
en
t f
ul
l e
le
ct
ro
ni
c 
se
ar
ch
 s
tr
at
eg
y 
fo
r 
at
 le
as
t o
ne
 d
at
ab
as
e,
 in
cl
ud
in
g 
an
y 
li
m
it
s 
us
ed
, s
uc
h 
th
at
 it
 c
ou
ld
 
 b
e 
re
pe
at
ed
. 
6
St
ud
y 
se
le
ct
io
n 
9
St
at
e 
th
e 
pr
oc
es
s 
fo
r 
se
le
ct
in
g 
st
ud
ie
s 
(i.
e.
, s
cr
ee
ni
ng
, e
li
gi
bi
lit
y,
 in
cl
ud
ed
 in
 s
ys
te
m
at
ic
 r
ev
ie
w
, a
nd
, i
f
 a
pp
li 
ca
bl
e,
 in
cl
ud
ed
 in
 th
e 
m
et
a-
an
al
ys
is
). 
6,
7
D
at
a 
co
lle
ct
io
n 
pr
oc
es
s 
10
D
es
cr
ib
e 
m
et
ho
d 
of
 d
at
a 
ex
tr
ac
ti
on
 fr
om
 r
ep
or
ts
 (e
.g
., 
pi
lo
te
d 
fo
rm
s,
 in
de
pe
nd
en
tl
y,
 in
 d
up
lic
at
e)
 a
nd
 a
ny
 
 p
ro
ce
ss
es
 fo
r 
ob
ta
in
in
g 
an
d 
co
n
fi
rm
in
g 
da
ta
 fr
om
 in
ve
st
ig
at
or
s.
 
6,
7,
8
D
at
a 
ite
m
s 
11
Li
st
 a
nd
 d
efi
ne
 a
ll 
va
ri
ab
le
s 
fo
r 
w
hi
ch
 d
at
a 
w
er
e 
so
ug
ht
 (e
.g
., 
PI
C
O
S,
 fu
nd
in
g 
so
ur
ce
s) 
an
d 
an
y 
as
su
m
pt
io
ns
 
 a
nd
 s
im
pl
ifi
ca
ti
on
s 
m
ad
e.
 
7,
8
R
is
k 
of
 b
ia
s 
in
 in
di
vi
du
al
 s
tu
di
es
 
12
D
es
cr
ib
e 
m
et
ho
ds
 u
se
d 
fo
r 
as
se
ss
in
g 
ri
sk
 o
f b
ia
s 
of
 in
di
vi
du
al
 s
tu
di
es
 (i
nc
lu
di
ng
 s
pe
ci
fic
at
io
n 
of
 w
he
th
er
 
 th
is
 w
as
 d
on
e 
at
 th
e 
st
ud
y 
or
 o
ut
co
m
e 
le
ve
l),
 a
nd
 h
ow
 th
is
 in
fo
rm
at
io
n 
is
 to
 b
e 
us
ed
 in
 a
ny
 d
at
a 
sy
nt
he
si
s.
 
7
Su
m
m
ar
y 
m
ea
su
re
s 
13
St
at
e 
th
e 
pr
in
ci
pa
l s
um
m
ar
y 
m
ea
su
re
s 
(e
.g
., 
ri
sk
 r
at
io
, d
iff
er
en
ce
 in
 m
ea
ns
). 
7,
8
Sy
nt
he
si
s 
of
 r
es
ul
ts
 
14
D
es
cr
ib
e 
th
e 
m
et
ho
ds
 o
f h
an
dl
in
g 
da
ta
 a
nd
 c
om
bi
ni
ng
 r
es
ul
ts
 o
f s
tu
di
es
, i
f d
on
e,
 in
cl
ud
in
g 
m
ea
su
re
s 
of
 c
on
- 
si
st
en
cy
 (e
.g
., 
I2
) f
or
 e
ac
h 
m
et
a-
an
al
ys
is
. 
6,
7,
8
Ad
ap
te
d 
fr
om
 M
oh
er
 D
, L
ib
er
at
i A
, T
et
zl
aff
 J,
 A
lt
m
an
 D
G
; P
R
IS
M
A 
G
ro
up
. P
re
fe
rr
ed
 r
ep
or
ti
ng
 it
em
s 
fo
r 
sy
st
em
at
ic
 r
ev
ie
w
s 
an
d 
m
et
a-
an
al
ys
es
: t
he
 P
R
IS
M
A 
st
at
em
en
t. 
PL
oS
 M
ed
 2
00
9;
6:
e1
00
00
97
. 
